EICHOR
● Active Not Recruiting
A Study of Guselkumab Subcutaneous Therapy in Participants With Moderately to Severely Active Crohn's Disease
Condition: Crohn Disease · Sponsor: Janssen Research & Development, LLC
About this study
The purpose of this study is to evaluate the efficacy and safety of guselkumab in participants with Crohn's disease.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (345)
| Digestive Health Specialists of the Southeast | Dothan, Alabama, United States | — |
| Advanced Gastro P.C | Chandler, Arizona, United States | — |
| Reliance Research | Scottsdale, Arizona, United States | — |
| Moore Clinical Trials, LLC | Little Rock, Arkansas, United States | — |
| Central Arkansas Veterans Healthcare System | Little Rock, Arkansas, United States | — |
| Om Research LLC 1 | Lancaster, California, United States | — |
| Om Research LLC | Lancaster, California, United States | — |
| United Gastroenterologists | Los Alamitos, California, United States | — |
| Paul Wallace MD | Los Angeles, California, United States | — |
| Clinnova Research | Orange, California, United States | — |
| Digestive System Healthcare | Pasadena, California, United States | — |
| Northshore Gastroenterology Research, LLC | San Diego, California, United States | — |
+ 333 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05197049